Abstract
Actinic keratosis (AK) develops on chronically sun-exposed skin and constitutes one of the most common diseases managed by dermatologists. The incidence of AKs continues to rise among aging as well as younger sun damaged populations worldwide, underscoring the importance of effective therapy options. Various treatments are available, including light-based therapies, topical therapies, and destructive therapies. Herein, we review the current management options for AKs and discuss emerging therapeutic agents.
| Original language | English |
|---|---|
| Pages (from-to) | S161-S166 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 18 |
| Issue number | 5 |
| State | Published - May 2019 |